Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-21

FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Losartan Potassium by Aurobindo Pharma Limited under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan Potassium (Losartan potassium)

Snippet

SUPPL AP for LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)